Page 12 - Colitis Foundation News Today

In recent years, microbiome research has started to shift its focus from the microbes themselves to the molecules they produce. After all, it’s these molecules that directly interact with human cells to influence a person’s health. But trying to iden

Browns will take on the Texans at NRG Stadium at 4:30 p.m.on Jan. 13

Evotec and Crohns & Colitis Foundation Enter Agreement to Advance ...

EQS-News: Evotec SE / Key word: Miscellaneous Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies 10.01.2024 /...

Evotec and Crohns & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies

Evotec SE EVO joined forces with the Crohn's & Colitis Foundation to advance drug discovery and identify novel therapies for inflammatory bowel disease (IBD).…

Evotec SE (NASDAQ: EVO) joined forces with the Crohn's & Colitis Foundation to advance drug discovery and identify novel therapies for inflammatory bowel disease (IBD).

Evotec’s end-to-end integrated research and development platform will be able to advance drug discovery for two drug targets which is why it has joined forces with the Crohn’s & Colitis Foundation.

"Once we identified the mechanism causing the colitis, we could then develop ways to overcome this problem..."

Erin L. Andrejcak passed away. This is the full obituary where you can share condolences and memories. Published in the Niagara Gazette on 2024-01-05.